Drawing for WE TAKE MEDICINE PERSONALLY

USPTO serial 77316878

WE TAKE MEDICINE PERSONALLY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JOINER, KATINA JACKSON
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WE TAKE MEDICINE PERSONALLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jayme M. Torelli

Jayme M. Torelli Hoffman Warnick LLC75 State Street, 14th FloorAlbany, NY 12207UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and pharmacogenetic applications of those pharmaceuticals, namely, cardiovascular pharmaceuticals, dermatological pharmaceuticals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations for anticoagulants, pharmaceutical preparations for antidepressants, pharmaceutical preparations for appetite suppressants, pharmaceutical preparations for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the inhalation treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for treating wounds, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical preparations for the treatment of bone diseases, pharmaceutical preparations for the treatment of respiratory diseases and asthma, pharmaceuticals, namely, lipid-lowering agents, pharmaceuticals, namely, psychotropics, pharmaceuticals for the treatment of fatigue, and pharmaceuticals for the treatment of autismACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 7, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 7, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 24, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Sep 23, 2011EX5GSOU EXTENSION 5 GRANTED—
Sep 21, 2011EXT5SOU EXTENSION 5 FILED—
Sep 21, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 22, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Mar 20, 2011EX4GSOU EXTENSION 4 GRANTED—
Mar 14, 2011EXT4SOU EXTENSION 4 FILED—
Mar 14, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 28, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Sep 27, 2010EX3GSOU EXTENSION 3 GRANTED—
Sep 24, 2010EXT3SOU EXTENSION 3 FILED—
Sep 24, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Apr 12, 2010EX2GSOU EXTENSION 2 GRANTED—
Apr 12, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 17, 2010EXT2SOU EXTENSION 2 FILED—
Mar 17, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2009EX1GSOU EXTENSION 1 GRANTED—
Oct 8, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 25, 2009EXT1SOU EXTENSION 1 FILED—
Sep 25, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 7, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 26, 2009CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Feb 20, 2009ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 10, 2008EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 7, 2008ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 7, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2008NPUBNOTICE OF PUBLICATION—
Sep 4, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 4, 2008ALIEASSIGNED TO LIE—
Aug 27, 2008CNEAEXAMINERS AMENDMENT MAILED—
Aug 26, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 26, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 26, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Aug 26, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 13, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 12, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 12, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2008CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 12, 2008CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 11, 2008DOCKASSIGNED TO EXAMINER—
Nov 2, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance